2.77xsubscribed
Himalaya Nutravedics India IPO
2.77xsubscribed
listed
2.77xsubscribed
₹2.40LMin. investment
Himalaya Nutravedics India Limited IPO Details
Issue size
₹26Cr
IPO type
SME
Market cap
₹93.35CrLower than sector avg
Price range
₹100 – ₹106
Listing exchange
BSE
RevenueApr 2025 - Mar 2026
₹43.06CrLower than sector avg
Listing date
29 Sep 2026
Lot size
1200 shares
Red Herring Prospectus
Read
Growth rate3Y CAGR
72.76%
Price range₹100 – ₹106
IPO type
SME
Lot size1200 shares
Issue size₹26Cr
Red Herring Prospectus
Read
Market cap
₹93.35CrLower than sector avg
RevenueApr 2025 - Mar 2026
₹43.06CrLower than sector avg
Growth rate3Y CAGR
72.76%
Himalaya Nutravedics India IPO Subscription Status
As on 22-Sep-26, 5:30 PM
Himalaya Nutravedics India IPO Timeline
- Pre-apply21 Sep 2026
- Bid start22 Sep 2026
- Bid end24 Sep 2026
- Allotment25 Sep 2026
- Release of funds28 Sep 2026
- Demat transfer28 Sep 2026
- Listing29 Sep 2026
About Himalaya Nutravedics India Limited
Himalaya Nutravedics India manufactures, markets and distributes Ayurvedic and nutraceutical formulations in India and undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies.
Incorporated on June 16, 2022, it commenced manufacturing in September 2022 at Cherlapally, Hyderabad. Its portfolio covers classical Ayurvedic formulations, proprietary Ayurvedic formulations and nutraceutical supplements in softgel and hardgel capsules, tablets, liquid orals, medicated oils and protein powders.
The company uses a hybrid model comprising own-brand products and third-party manufacturing. Own-brand revenue rose to 51.1% of FY26 revenue, from 19.6% in FY25 and 28.1% in FY24; third-party manufacturing contributed 48.8%, 80.3% and 71.9%, respectively.
Own-brand products are marketed through a doctor-centric, prescription-led offline model supported by stockists and super-stockists, while contract manufacturing is executed against client purchase orders and specifications. Softgel capsules generated 59.7% of FY26 revenue, medicated oils 29.9%, tablets 7.6% and other products 2.6%.
The company operates one integrated leased manufacturing facility of about 12,544 sq. ft. with around 63 machines and currently runs one eight-hour shift. Per-shift installed capacity is 400,000 softgels, 3,000 bottles of medicated oil, 150,000 tablets, 500 bottles of liquid orals, 150,000 hardgels and 200 bottles of protein powder. FY26 capacity utilisation was 63.7% for softgels, 90.2% for medicated-oil bottles, 17.8% for tablets, 13% for liquid-oral bottles, 4.2% for hardgels and 10.8% for protein-powder bottles.
The company marketed products across 17 states as of March 31, 2026. Kerala contributed 49.3% of FY26 revenue, followed by Gujarat at 13.2%, Uttar Pradesh at 11.6%, Telangana at 9.4% and Andhra Pradesh at 6.2%. Third-party manufacturing is concentrated in Kerala, which contributes about 90% of that segment's revenue.
Checklist
Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial
health at a glance and identify quality investment opportunities easily
Objectives of Himalaya Nutravedics India Limited IPO
Working capital requirements
51.80%
Investment in marketing & sales expansion
28.30%
General corporate purposes
19.80%
Compare
Companies in this sector
Sun Pharmaceutical Industries Ltd
Divi's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Himalaya Nutravedics India IPO Contact Details
Company NameHimalaya Nutravedics India Limited
How to apply for Himalaya Nutravedics India IPO?
- Step 1
Log in to your Upstox account to access IPO investments. Next, select the current IPO section.
- Step 2
Specify IPO details. Enter the number of lots and the price you wish to apply for.
- Step 3
Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.
- Step 4
Mandate Notification. Your UPI app will receive a mandate notification to block funds.
- Step 5
Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.